Form 4: uniQure N.V. Executive Pierre Caloz Reports Stock Option Grant and Share Acquisition

Chief Operating Officer Pierre Caloz of uniQure N.V. reports acquisition of restricted share units and stock options.

Summary

• Pierre Caloz, Chief Operating Officer of uniQure N.V., filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Caloz acquired 33,000 restricted share units and 57,000 stock options.
• The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to continued relationship with the Issuer.
• The stock options vest 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to continued relationship with the Issuer.
• The exercise price of the stock options is $5.59.
• Following the reported transactions, Caloz beneficially owns 118,643 ordinary shares and 57,000 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition of shares and options by a key executive generally indicates confidence in the company's prospects. However, it's a routine filing and doesn't necessarily imply a major shift in the company's outlook.

Positives

• The acquisition of shares and options by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedules of the restricted share units and stock options are contingent upon the Reporting Person's continued relationship with the Issuer.

Industry Context

This filing is a routine disclosure related to executive compensation and equity ownership, common in the biotechnology industry.

Comparison to Industry Standards

• Stock option grants and restricted share units are common forms of executive compensation in the biotechnology industry, used to align management's interests with those of shareholders.
• Vesting schedules are typical, designed to incentivize long-term commitment and performance.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.

Key Dates